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Protein kinase C (PKC) enhances NMDA receptor (NMDAR)-mediated currents and promotes NMDAR delivery to the cell surface via
SNARE-dependent exocytosis. Although the mechanisms of PKC potentiation are established, the molecular target of PKC is unclear.
Here we show that synaptosomal-associated protein of 25 kDa (SNAP-25), a SNARE protein, is functionally relevant to PKC-dependent
NMDAR insertion, and identify serine residue-187 as the molecular target of PKC phosphorylation. Constitutively active PKC delivered
via the patch pipette potentiated NMDA (but not AMPA) whole-cell currents in hippocampal neurons. Expression of RNAi targeting
SNAP-25 or mutant SNAP-25(S187A) and/or acute disruption of the SNARE complex by treatment with BoNT A, BoNT B or SNAP-25
C-terminal blocking peptide abolished NMDAR potentiation. A SNAP-25 peptide and function-blocking antibody suppressed PKC po-
tentiation ofNMDAEPSCs atmossy fiber-CA3 synapses. These findings identify SNAP-25 as the target of PKCphosphorylation critical to
PKC-dependent incorporation of synaptic NMDARs and document a postsynaptic action of this major SNARE protein relevant to
synaptic plasticity.
Introduction
NMDARs are glutamate-gated ion channels and play a pivotal
role in the regulation of synaptic function in the brain. NMDARs
are heteromeric assemblies of NR1, NR2, and NR3 subunits,
which cotranslationally assemble in the endoplasmic reticulum
(ER) to form functional channelswith differing physiological and
pharmacological properties (Wenthold et al., 2003; Pe´rez-Otan˜o
and Ehlers, 2005; Lau and Zukin, 2007). NMDAR-mediated
Ca2 influx is essential for synaptogenesis, experience-dependent
synaptic remodeling, and long-lasting changes in synaptic effi-
cacy such as long-term potentiation (LTP) and depression
(LTD), cellular processeswidely believed to underlie learning and
memory (Collingridge et al., 2004; Malenka and Bear, 2004).
Recent studies indicate that NMDARs serve not only as a trigger
of synaptic plasticity, butmay also contribute to the expression of
LTP and LTD (Lau and Zukin, 2007).
PKC plays a critical role in memory formation and storage
(Wang et al., 2006), induction of LTP (Ben-Ari et al., 1992), and
vesicular exocytosis (Morgan et al., 2005). PKC increases
NMDAR channel opening rate in Xenopus oocytes and promotes
NMDAR insertion at the cell surface via SNARE-dependent exo-
cytosis (Lan et al., 2001a). PKC phosphorylates NR1 at Ser890
and Ser896 near an RXR ER retention motif and promotes
NMDAR forward trafficking (Scott et al., 2001, 2003). Although
NMDARs are a known functional target of PKC potentiation,
the direct molecular target of PKC phosphorylation is unclear.
Target PKC and PKA phosphorylation sites have been identi-
fied on the NR1, NR2A, and NR2B subunits (Leonard and
Hell, 1997; Tingley et al., 1997). However, NMDARs assem-
bled from mutant subunits lacking all known sites of PKC
phosphorylation show marked PKC potentiation (Zheng et
al., 1999; but see Liao et al., 2001), suggesting that the molec-
ular target of PKC is a receptor-associated signaling and/or
trafficking protein.
Emerging evidence indicates a role for the SNARE family of
membrane fusion proteins in trafficking of postsynaptic gluta-
mate receptors (Lledo et al., 1998; Lan et al., 2001a; Lu et al., 2001;
Washbourne et al., 2004). The synaptosomal-associated protein
of 25 kDa (SNAP-25) is a member of the SNARE family and a
known target of PKC phosphorylation (Shimazaki et al., 1996).
SNAP-25 assembles with syntaxin-1 and vesicle-associatedmem-
brane protein-2 (VAMP2/synaptobrevin-2) via SNAREmotifs to
form the SNARE complex, the minimal machinery necessary for
exocytosis of neurotransmitter vesicles at the presynaptic termi-
nal (Jahn et al., 2003). SNAP-25, syntaxin-1, andVAMP2 localize
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to biochemical fractions of postsynaptic densities (PSDs), consis-
tent with the possibility that they also participate in trafficking of
postsynaptic receptors (Jordan et al., 2004; Cheng et al., 2006).
The present study was undertaken to identify the molecular
target of PKC phosphorylation functionally relevant to PKC-
induced insertion of NMDARs at the cell surface of neurons.
SNAP-25 is implicated in vesicular fusion and/or docking at pre-
synaptic terminals (Washbourne et al., 2002a) and PKC phos-
phorylation of Ser187 in SNAP-25 is important to vesicular
recruitment in adrenal chromaffin cells (Nagy et al., 2002). Here
we show that PKC phosphorylation of SNAP-25 at Ser187 is crit-
ical to PKC-induced, SNARE-dependent insertion of NMDARs
at synaptic sites, a mechanism relevant to synaptic plasticity.
Materials andMethods
DNA constructs. NR1100 (NR1-4b) and NR2A cDNAs in pBluescript SK
() vector were linearized at the 3 end with BamHI and NotI, respec-
tively, and used for in vitro transcription of mRNA. WT and 20
(dominant-negative) mutant constructs of SNAP-25 in pcDNA3 were
gifts from Dr. Roger Y. Tsien (Howard Hughes Medical Institute, Uni-
versity of California, San Diego, CA). SNAP-25 constructs were linearized
at the 3 end with EcoRI. Capped mRNAs were synthesized as runoff tran-
scripts from linearized plasmid cDNAs with T7 polymerase (mMessage
mMachine transcription kit; Ambion; 2 h at 37°C).
Mutagenesis. The SNAP-25 protein sequence harbors 3 sites that con-
form to the PKC consensus phosphorylation motif (S/T-X-R/K): Ser28,
Thr29 and Ser187. These residues in SNAP-25 were mutated into Ala or
Asp by site-directed mutagenesis, singly or altogether using the
QuikChange XL Site-Directed Mutagenesis Kit according to the manu-
facturer’s protocol (Stratagene). Themutagenic primer sequences for the
S187A mutation were (5 to 3): GATCATGGAGAAGGCTGACGC-
CAACAAAACCAGAATTG and CAATTCTGGTTTTGTTGGCGTCAGC
CTTCTCCATGATC; for S187D were GATCATGGAGAAGGCTGAC-
GACAACAAAACCAGAATT GATG and CATCAATTCTGGTTTTGT-
TGTCGTCAGCCTTCTCCATGATC; for S28AT29A were GGCTGA-
TGAGTCCCTCGAGGCCGCCCGTCGCATGCTGC and GCAGCAT-
GCGACGGGCGGCCTCGAGGGACTCATCAGCC. Introduction of an
XhoI site (underlined) in the S28AT29A primers allowed fast screening
of the mutant by restriction digest.
Subcloning. For transfection into HEK-293 cells and neurons in cul-
ture,WT andmutant SNAP-25 cDNAs were subcloned into the pIRES2-
EGFP vector (BD Biosciences Clontech), which allows production of a
single bicistronic mRNA containing SNAP-25 and EGFP. SNAP-25
cDNAswere excised frompcDNA3with BamHI (5) and EcoRI (3), and
pIRES2-EGFP was cut with BglII (5) and EcoRI (3) enzymes and the 5
end dephosphorylated by CIAP. The fragments were ligated together
overnight at 16°C using T4 ligase (Promega) or Quick Ligation kit (New
England Biolabs) at a molar ratio of 1:3 (vector:insert). The final con-
structs and orientation of inserts were confirmed by direct sequencing.
Lentiviral-mediated SNAP-25 RNAi. Double-stranded RNAi se-
quences targeting distinct regions of mouse SNAP-25 (engineered to
mimic endogenous microRNA structure) were subcloned into a
pcDNA6.2-GW/EmGFP-miR vector (Invitrogen). Cocistronic expres-
sion of EmGFP and targeting microRNA enabled visual identification of
cells expressing RNAi. The sense DNA strand coding for SNAP-25
RNAi-1 is TGCTGTACAGGGACACACACAAAGCCGTTTTGGCCA-
CTGACTGACGGCTTTGTGTGTCCCTGTA and that of SNAP-25
RNAi-2 is TGCTGATATGACGGAGGTTTCCGATGGTTTTGGCC-
ACTGACTGACCATCGGAACTCCGTCATAT. For nontargeting (NT,
control) RNAi, a sequence that does not target any known vertebrate
gene was used (GAAATGTACTGCGCGTGGAGACGTTTTGGCCAC-
TGACTGACGTCTCCACGCAGTACATTT ) (bolded regions represent
the sequences corresponding to coding nucleotides in the mouse
SNAP-25 cDNA). All constructs and orientation of inserts were con-
firmed by sequencing. To express SNAP-25 RNAi using a lentivirus, the
SNAP-25 RNAi-2 sequence was excised by SalI and XhoI and subcloned
into a self-inactivating lentiviral transfer vector (pCMV #207, gift from
Antonia Follenzi, Albert Einstein College of Medicine). 293T cells in 15
mm plates were cotransfected with the transfer vector and packaging
plasmids pMDL, pRev, and pVSV-G using the calcium phosphate
method as described previously (Follenzi andNaldini, 2002). Forty-eight
hours later, the medium was collected, filtered through a 0.45 m filter,
and centrifuged at 70,000 g for 3 h. The viral pellet was resuspended in
200 l of sterile PBS. All viral preparations were used after dilution to a
concentration of 1:100 with medium.
Electrophysiology of NMDARs expressed in Xenopus oocytes. Adult fe-
male Xenopus laevis frogs (Nasco) were anesthetized in 0.15% 3-amino-
benzoic acid ethyl ester (Sigma) and their oocytes were isolated with
collagenase B (0.2% w/v) and prepared as described(Kushner et al.,
1988). Stage V and VI oocytes were microinjected with 4–8 ng of
NR1100/NR2A (1:3 by weight) cRNA. Two days after injection, they were
injected with either WT or mutant SNAP-25 cRNA (20 ng). Two elec-
trode whole-cell voltage-clamp recording was performed 1 d after the
injection of SNAP-25 cRNA inMg2-free, Ca2 or Ba2 (1 mM) Ringer
solution withmicroelectrodes filled with 3 MKCl, 10mMHEPES, pH 7.2,
using GeneClamp 500 (Molecular Devices, Foster City, CA). Data were
digitized with pCLAMP6 (Molecular Devices). Responses were elicited
by bath application of 300 M NMDA with 10 M glycine at a holding
potential of60mV. Endogenous PKCwas activated by bath application
of the phorbol ester 12-O-tetradecanoylphorbol 13-acetate (TPA, 100
nM; Sigma) for 10min. PKCpotentiationwas expressed as the ratio of the
steady-state currents after TPA treatment to those obtained before TPA
application. All experiments were performed at room temperature (RT).
Data are presented as mean SEM.
Western blotting for p-SNAP-25 and SNAP-25 in HEK-293 cells and
cortical neurons. For HEK-293 cells, 5 106 cells (ATCC) were seeded in
60mmdish and transfectedwithWTormutant SNAP-25/pIRES2-EGFP
constructs (6 g) using Lipofectamine 2000 (Invitrogen). Twenty-four
hours after transfection, cells were treated with vehicle (DMSO control)
or TPA (100 nM) for 15 min, scraped to one side, and pelleted by centrif-
ugation. For neurons, one cortical hemisphere was trypsinized, tritu-
rated, and plated on to a 60 mm dish in Minimal Essential Medium
(MEM, Invitrogen) for 24 h and switched to Neurobasal medium sup-
plemented with B27 and GlutaMax (Invitrogen). Neurons at 9 days in
vitro (DIV) in culture were stimulated with TPA (100 nM) with or with-
out bisindolylmaleimide I (Bis, 1 M, Calbiochem), and with or without
phosphatase inhibitors okadaic acid (100 nM, Calbiochem) and cyclo-
sporin A (CsA, 2 M) at 37°C for 15 min. TPA, Bis, and CsA were dis-
solved in DMSO as 10,000 stock solutions. Following treatment,
neurons were rinsed once with ice-cold PBS and scraped to one side
(Nunc) in PBS supplemented with 1% protease inhibitor (Sigma) and
1%phosphatase inhibitor cocktail 1 (Sigma). Following centrifugation at
16,000  g at 4°C for 1 min, pelleted cells were lysed in lysis buffer
containing the following (in mM): 25 Tris-HCl, 100 NaCl, 5 EDTA, 5
EGTA, 1% Triton X-100, 1% protease inhibitor, and 1% phosphatase
inhibitor I (Sigma), pH 7.40, at 4°C for 30 min. Insoluble material was
spun down at 16,000 g for 15 min and protein content in the superna-
tant was subjected to BCA protein assay. Total protein (30 g) was
loaded on to a 4–12% Bis-Tris acrylamide gel (Invitrogen) and trans-
ferred for 1 h (Novex system, Invitrogen) on to a PVDF membrane.
Membranes were blocked in 5% nonfat dry milk in TBST (0.05% Tween
20) for 30 min at room temperature (RT), incubated with an anti-p-
SNAP-25 antibody (1:500; raised against the peptide MEKADS-PO4
3–-
NKTRI corresponding to residues 182-192 of SNAP-25 including
p-Ser187 in the center) (Iwasaki et al., 2000), or anti-SNAP-25 antibody
(directed against the N terminus, 1:3000–5000, BD Transduction Labo-
ratories), and detectedwith anti-rabbit (1:5000) or anti-mouse horserad-
ish peroxidase (1:5000, GE Healthcare) secondary antibodies and
enhanced chemiluminescence. Band intensities were quantified with
Scion Image v. 4.0.3.2 (Scion) or ImageJ (NIH).
Immunofluorescence staining of SNAP-25 and p-SNAP-25 in HEK-293
cells and neurons. HEK-293 cells (105) were seeded on to 12 mm cover-
slips in a 24-well plate and transfected with WT or mutant SNAP-25/
pIRES2-EGFP 1 d after. Cells were incubated with a transfectionmixture
containing 0.4 g of DNA with 1.2 l of FuGENE (Roche Applied Sci-
ence) in OptiMEM (Invitrogen). HEK cells at 24–30 h posttransfection
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were stimulated with TPA (100 nM) with or without Bis (1 M) for 15
min. Cells were fixed in 4% paraformaldehyde for 5–10 min at RT,
blocked, and permeabilized in 10% normal goat serum, 0.2% bovine
serum albumin, and 0.1% Triton X-100 in PBS (contained 10 mM phos-
phate, 138 mM NaCl and 2.7 mM KCl, pH 7.4). The p-Ser187-SNAP-25
antibody was a gift from M. Takahashi (Kitasato University, Kitasato,
Japan). Rabbit (p-SNAP-25, 1:250) and mouse (SNAP-25, 1:500, BD
Biosciences PharMingen) primary antibodies were incubated together at
4°C overnight, andwere labeled with secondary antibodies conjugated to
either AMCA, Alexa Fluor 488, Cy2 or Cy3 fluorophores (Jackson Im-
munoresearch or Invitrogen). Coverslips weremounted with an antifade
reagent, ProLong (Invitrogen). Stained cells were visualized and photo-
graphed with an Olympus AX70 microscope using a 60 PlanApo oil-
immersion lens (NA 1.40) and digitized using MagnaFire software (v.
2.1). Quantification of p-SNAP-25 intensity levels was performed by
selecting for the entire HEK cell, rather than the leading edge, because it
was not technically possible to arbitrarily draw the boundaries under
basal conditions (low p-SNAP-25 levels). Thus, values as reported for
HEK-293 cells may represent an underestimate of the true levels of
p-SNAP-25 at the leading edge. Quantification of p-SNAP-25 intensity
levels in neurons was performed by selecting the dendrites.
Electrophysiology of NMDA-elicited currents in hippocampal neurons.
Dissociated cultures of hippocampal neurons were prepared from em-
bryonic day 18 rats according to the methods of Banker and Goslin
(1988). Hippocampal neurons (DIV 7–14) were transfected with 4g of
WT or SNAP-25(S187A) in pIRES2-EGFP vector using a modified cal-
cium phosphate method (Jiang et al., 2004) for 1–2 h that involved dis-
solution of the calcium phosphate precipitate in slightly acidic medium
(Neurobasal) that had been equilibrated with 8% CO2. Twenty-four
hours later,NMDA-elicitedwhole-cell currentswere recorded by 5 s bath
application of 100 M NMDA and 10 M glycine. Near steady-state cur-
rentsweremeasured at the endof the brief perfusion of agonists (5 s). The
external solution contained the following (inmM): 145 NaCl, 2.5 KCl, 10
HEPES, 10 glucose, 2 CaCl2, pH 7.4 and 10 mM sucrose to adjust
osmolality to 310–320 mOsm. Recording pipettes were pulled from bo-
rosilicate glass (A-MSystem) and open-tip resistance after heat polishing
(Narishige) was typically 2–5 M with an internal solution of (in mM):
120CsCH3SO3, 10 CsCl, 10HEPES, 10 EGTA, 4MgATP, 0.4NaGTP, 0.1
CaCl2, 0.5MgCl2, 5 phosphocreatine, adjusted to pH 7.3 with CsOH and
290–300 mOsm. The constitutively active form of PKC (PKM, 2 nM;
Sigma) was dialyzed into the cell by its inclusion in the pipette, and
NMDA currents were continually monitored and recorded using an
AxoPatch-1D amplifier (Molecular Devices) and digitized by the 1322A
Digidata D/A converter (Axon) and pCLAMP 9.2 software. Signals were
low-pass filtered at 2 kHz and digitized at 5 kHz. Vh	60 mV. Poten-
tiation of NMDA currents was measured at 5 min after break-in and
delivery of PKM and was expressed as a ratio to the amplitude of the
basal current recorded at 0 min. SNAP-25 C-terminal peptides (70%
purity) were custom-synthesized by Anaspec, and used at 10M in the
pipette. Peptides were dissolved in water (as 1000 stocks), aliquoted
and thawed for use on the day of experiment. The sequence for the
blocking peptide was MEKADANKTRI and scrambled peptide was
KANAKTDEIRM. For peptide recordings, after the washout of NMDA
and glycine, S-AMPA (25 M; Sigma) was bath-applied for 1 s to simul-
taneously monitor AMPAR- and NMDAR-mediated currents in the
same cell. Chelerythrine (1 M), an inhibitor of the catalytic domain of
PKC, was applied at the end of experiments to confirm PKM activity.
Clostridium botulinum neurotoxins (BoNT; from List Biological Labora-
tories) were reconstituted according to manufacturer’s instructions and
applied to cells for 1 h at 37°C at 1 g/ml (6.7 nM) final concentration.
Electrophysiology of isolated NMDA EPSCs in hippocampus. Transverse
hippocampal slices were prepared from P16-P21 C57BL/6 mice, as de-
scribed previously (Christensen et al., 2004). Electrophysiological re-
cordings were performed from neurons visually identified by infrared
differential interference contrast microscopy using a 40 water-
immersion objective. All experiments were performed at room temper-
ature (22–25°C). Slices were continuously perfused with (in mM): 124
NaCl, 3 KCl, 1.25 KH2PO4, 1 MgCl2, 2 CaCl2, 26 NaHCO3, and 10
glucose, pH 7.3 (300 mOsm), supplemented with picrotoxin (50 M),
CNQX (10M) and LY303070 (the active isomer of GYKI-53655; 25M)
to isolate synaptic responses mediated by NMDARs. Drugs were applied
by switching between gravity-fed perfusion lines. EPSCs were evoked by
paired-pulse stimulation (interstimulus interval of 100 ms) of mossy
fibers by placing a bipolar electrode in the dentate granule cell layer.
Tight-seal (
1 G) whole-cell recordings were obtained from CA3 py-
ramidal neurons using patch pipettes pulled from borosilicate glass that
had a resistance of 3–5 M when filled with the following internal solu-
tion (in mM): 130 CsMeSO3, 4 NaCl, 10 HEPES, 0.2 EGTA, and 10 TEA,
5 QX-314, 4 ATP and 0.5 GTP (pH 7.3, 287 mOsm). PKC activators,
PDBu (1 M) or PKM (1 M), and anti-SNAP25 antibody (20 mg/ml;
SMI 81, SternbergerMonoclonals), denatured (boiled) anti-SNAP25 an-
tibody, SNAP-25 scrambled or blocking peptide (50 M) alone or in
combination were used in the patch pipette. Series resistance (20M)
was regularly monitored during recordings, and cells were rejected if
resistance changed
15% during the experiment. Data were filtered at 2
kHz, digitized, acquired through Axopatch 200A amplifier (Molecular
Devices) and pClamp 8.0 software. Statistical significance was evaluated
by the two-tailed unpaired Student’s t test.
Western blot analysis of NMDAR surface expression. Cortical neu-
rons in culture (DIV 9–11) were treated with TPAwith or without phos-
phatase inhibitors, washed, and treated with membrane-impermeable EZ-
Link Sulfo-NHS-SS-Biotin (Sulfosuccinimidyl 2-(biotinamido)-ethyl-1,
3-dithiopropionate, 1 mg/ml; Pierce) for 30 min at 4°C. Proteins were
extracted in lysis buffer containing Tris-HCl (pH 7.40, 25 mM), NaCl
(150 mM), EDTA (pH 8.0, 1 mM), SDS (0.1%), Na deoxycholate (0.5%),
and protease and phosphatase inhibitors for 30 min at 4°C, and surface
proteins were pulled down with NeutrAvidin beads (Pierce) O/N at 4°C
and released from the beads by boiling with DTT (1 mM). Total and
surface proteins were subjected to SDS-PAGE and Western blotting us-
ing a monoclonal antibody 54.1 directed against the extracellular loop of
the NR1 subunit (1:5000; gift from J.H. Morrison, Mount Sinai) or
GluR1 (1:1000, Millipore AB1504).
Results
Ser187, but not Ser28 and Thr29, of SNAP-25 is an important
PKC target
To examine a possible role for SNAP-25 as a PKC target critical to
NMDAR insertion, we expressed NR1-4b/NR2A receptors to-
gether with WT and mutant SNAP-25 in Xenopus oocytes and
recorded NMDA-elicited whole-cell currents before and after
PKC activation. Xenopus oocytes are geometrically simple cells
and provide a homogeneous source of NMDARs. NR1-4b/NR2A
receptors exhibit the highest surface expression (Okabe et al.,
1999) and highest PKC potentiation in oocytes (Durand et al.,
1993). Application of the PKC-activating phorbol ester TPA (100
nM, 10 min) potentiated NMDA currents by 8-fold in cells
expressingNMDARs in the absence of exogenous SNAP-25 (con-
trol; Fig. 1a). PKC potentiation, defined as the ratio of steady-
state NMDA current after PKC activation to that before PKC
activation, was 8.30 0.67 (n	 26, p 0.001 vs control; in 1mM
Ca2). The specific PKC inhibitor Ro-31-8220 (5 M, 15 min
preincubation) completely abolished TPA-induced potentiation
of NMDA-elicited currents (from 4.30  0.56 to 1.01  0.29-
fold, n	 3, p 0.01; 1 mM Ba2), indicating that TPA potenti-
ation is PKC-mediated. Expression of wild-type (WT) SNAP-25
did not significantly alter basal or potentiated NMDA currents
(Fig. 1b). Expression of dominant-negative SNAP-25 (lacking the
last 20 amino acids in the C terminus, SNAP-2520 or dnSNAP-
25) (Yao et al., 1999; Lan et al., 2001a) markedly reduced basal
NMDA currents (defined as the steady-state phase of the current
before PKC potentiation and normalized to WT SNAP-25 cur-
rent amplitudes; 25.7 6.9% of WT, n	 20, p 0.001; Fig. 1c)
and PKC potentiation (normalized to WT SNAP-25 potentia-
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tion; 51.8  6.9% of WT, n 	 20, p  0.01; Fig. 1c). These
findings demonstrate a role for SNAP-25 in PKC potentiation of
NMDARs. The incomplete (50%) block of basal currents or
potentiation could reflect the inability of dnSNAP-25 to com-
pletely suppress endogenous SNAP-25 function, the existence of
additional pathways for receptor exocytosis and/or a contribu-
tion of enhanced channel opening to PKC potentiation.
PKC potentiates NMDA-elicited currents in hippocampal
neurons primarily via rapid insertion of NMDARs at the cell
surface (Lan et al., 2001a). Although SNAP-25 is a known target of
PKC phosphorylation, a role for PKC-
dependent phosphorylation of SNAP-25
in NMDAR potentiation is unclear. To
examine the possibility that SNAP-25 is a
functionally relevant target of PKC phos-
phorylation and to identify residue(s) in
SNAP-25 that are critical to PKC pote-
ntiation of NMDARs, we expressed
NMDARs together with WT or mutant
SNAP-25 lacking one or more of its puta-
tive phosphorylation sites (Ser187, Ser28,
Thr29) in Xenopus oocytes. Replacement
of the serine residue 187 in SNAP-25 with
an alanine (Ser187Ala or S187A) mark-
edly reduced basal NMDA currents
(27.5  3.4% of WT, n 	 22, p 0.001;
Fig. 1d) and degree of PKC potentiation
(59.9 7.5%ofWT, n	 22, p 0.01; Fig.
1d), reductions similar to those observed
for dnSNAP-2520. Thus, in oocytes, a
single point mutation in SNAP-25 is suf-
ficient to suppress constitutive and regu-
lated NMDAR exocytosis. In contrast,
elimination of the other two putative sites
of PKC phosphorylation, Ser28 and
Thr29, even in combination did not de-
tectably alter either basal or potentiated
currents (basal currents, 119  13% of
WT, n	 10, p
 0.05; PKC potentiation,
94.5 4.8% ofWT, n	 10, p
 0.05; Fig.
1e). These findings indicate that Ser187 is
the exclusive site of PKC phosphorylation
in SNAP-25 that is functionally relevant to
NMDAR insertion. The phosphomimetic
mutant SNAP-25(S187D), which mimics
phosphorylation by replacement of Ser
with the negatively charged residue as-
partate (D), markedly enhanced basal
NMDA currents even in the absence of
PKC activation (186 31%ofWT, n	 5,
p  0.05; Fig. 1f), but did not detectably
alter PKC potentiation (88.0  6.1% of
WT, n 	 5, p 
 0.05; Fig. 1f–i). The fact
that mutation of Ser187 into Asp, a non-
phosphorylatable residue, does not affect
PKC potentiation suggests that Ser187
of SNAP-25 may not be the only target
of PKC phosphorylation involved in
NMDAR trafficking. These results suggest
that Ser187 of SNAP-25 is a target of PKC
phosphorylation relevant to NMDAR po-
tentiation in oocytes.
PKC phosphorylates SNAP-25 at Ser187
To directly show that PKC phosphorylates SNAP-25 at Ser187,
we performed two experiments. First, we expressedWT andmu-
tant SNAP-25(S187A) under the pIRES2-EGFP vector, which al-
lows transfected cells to be identified by means of its green
fluorescence, in HEK-293 cells and assessed PKC-induced phos-
phorylation by Western blot analysis. Application of PKC-
activating phorbol ester TPA (100 nM, 15 min) to HEK-293 cells
induced phosphorylation of SNAP-25 at Ser187, as assessed by
Western blots probed with a phospho-specific antibody (Fig. 2a,
Figure 1. Ser187, but not Ser28 and Thr29, of SNAP-25 is critical to PKC potentiation of NMDA currents. a–f, Representative
experiments showing PKC potentiation of NMDA-elicited currents recorded from Xenopus laevis oocytes expressing NR1-4b/NR2A
andWTormutant SNAP-25, 24hafter injectionof SNAP-25 cRNA.NMDAcurrentswereelicitedbybathapplicationofNMDA(N,300
M with 10M glycine; gray bars above current traces) and recorded by two-electrode voltage clamp at Vh	60 mV in 1 mM
Ca 2 and 0 Mg 2. a, Application of the PKC-activating phorbol ester 12-O-tetradecanoylphorbol 13-acetate (TPA, 100 nM, 10
min, black bar) potentiated NMDA currents by8-fold in control (H2O-injected) oocytes. PKC potentiation is defined as the ratio
of steady-state NMDA current after to that before PKC activation. b, Expression of WT SNAP-25 does not detectably alter PKC
potentiation of NMDA-elicited currents. c, The dominant-negative mutant of SNAP-25, SNAP2520, markedly reduced the basal
NMDA current and PKC potentiation. Note the change in scale. d, A pointmutation inwhich Ser187was replaced by Ala (S187A) in
SNAP-25 reduced both basal NMDA currents and PKC potentiation to an extent indistinguishable from SNAP-2520. e, Replace-
ment of Ser28 and Thr29 by Ala (SNAP-25 S28A/T29A) did not detectably alter basal NMDA currents or PKC potentiation. f, The
phosphomimetic mutant, SNAP-25 S187D, markedly enhanced basal NMDA currents without affecting PKC potentiation. g, h,
Summary bar graphs showing effects of WT and mutant SNAP-25 on basal NMDA currents (g) and PKC potentiation (h). PKC
potentiation in uninjected oocytes and oocytes expressing mutant SNAP-25 constructs was normalized to that in cells expressing
WT SNAP-25. Numbers on bars indicate the number of oocytes (n) involving 3–5 independent experiments performed from
different batches of oocytes. Data represent means SEM. *p 0.05; **p 0.01; ***p 0.001.
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top). Coapplication of the potent and spe-
cific PKC inhibitor bis-indoylmaleimide I
(Bis, 1 M) completely abolished TPA-
induced phosphorylation of SNAP-25,
confirming that TPA acts via PKC to exert
its effects (Fig. 2a). In contrast, cells ex-
pressing mutant SNAP-25(S187A) exhib-
ited robust SNAP-25 expression, but little
or no p-SNAP-25 either before or after
application of TPA (Fig. 2a). Stripping
and reprobing the membrane with an
antibody directed against full-length
SNAP-25 revealed equal loading of sam-
ples and absence of SNAP-25 in untrans-
fected cells, indicating the specificity of
the antibody.
Second, we expressed WT and mutant
SNAP-25(S187A) in HEK-293 cells and
performed immunolabeling of total and
p-SNAP-25. Under basal conditions,
SNAP-25 localized to the plasma mem-
brane, as well as to the Golgi appara-
tus (perinuclear labeling); little or no
p-SNAP-25 was detected (Fig. 2b). Appli-
cation of TPA did not detectably alter the
abundance or cellular localization of total
SNAP-25, but produced a dramatic in-
crease in p-SNAP-25 immunofluores-
cence, prominent at the edges of the cells
(Fig. 2c). The specific PKC inhibitor Bis
again abolished TPA-induced phosphor-
ylation of SNAP-25, indicating that
SNAP-25phosphorylation isPKC-mediated
(Fig. 2d). In contrast, cells expressingmu-
tant SNAP-25(S187A) exhibited robust
SNAP-25 immunofluorescence, but little or no p-SNAP-25 immu-
nofluorescence either before or after application of TPA (Fig. 2e–g).
These findings demonstrate that PKCpromotes phosphorylation of
SNAP-25 at Ser187 in HEK-293 cells. Although we cannot rule out
additional sites of phosphorylation at Ser28 and Thr29, data in Fig-
ure 1 indicate that were phosphorylation of these sites to occur, it
would not be functionally relevant to PKC potentiation.
The results thus far demonstrate that SNAP-25 is a function-
ally relevant target of PKC involved in PKC potentiation of
NMDARs in oocytes and that PKC phosphorylates SNAP-25 at
Ser187 in HEK-293 cells. To examine whether Ser187 of
SNAP-25 is a target of PKC phosphorylation in neurons, we per-
formed two experiments. First, we treated cortical neurons (DIV
19) with TPA or vehicle and subjected cell lysates toWestern blot
analysis. Cortical neurons exhibited little or no p-SNAP-25 ba-
sally, whereas upon TPA stimulation, p-SNAP-25 was markedly
induced (Fig. 3a). These findings are in confirmation of observa-
tions in PC12 cells (Iwasaki et al., 2000), chromaffin cells (Nagy et al.,
2002) and HEK-293 cells (Fig. 2). Application of okadaic acid
(OA, 100 nM) with cyclosporine A (CsA, 2 M), a mixture that
inhibits protein phosphatases 1 (PP1), PP2A, and PP2B (also
known as calcineurin), enhanced TPA-elicited phosphorylation of
SNAP-25 at Ser187 (Fig. 3a, top); the mixture alone did not in-
duce phosphorylation of SNAP-25 at Ser187 (data not shown).
Application of the specific PKC inhibitor Bis completely abol-
ished TPA-induced phosphorylation of SNAP-25 at Ser187 in the
absence or presence of phosphatase inhibitors (Fig. 3a, top).
Summary data indicate that the phosphatase inhibitors enhanced
TPA-induced phosphorylation of SNAP-25 by2-fold and that
Bis completely abolished phosphorylation (TPA vs control,
TPA Bis vs TPA and TPA CsA OA Bis vs TPA, n	 4,
p 0.001; TPACsAOA vs TPA, n	 4, p 0.05; Fig. 3b). In
contrast, neither PKA inhibitors (PKI(14-22) and H-89) nor a
CaMKII inhibitor (KN-93) attenuated SNAP-25 phosphoryla-
tion in neurons (supplemental Fig. 1, available at www.jneurosci.
org as supplemental material). These findings strongly suggest
that the TPA-induced phosphorylation of SNAP-25 is PKC-
dependent in HEK-293 cells and neurons.
Second, we performed immunolabeling of hippocampal neu-
rons (DIV 14) with antibodies to SNAP-25 and p-SNAP-25. Un-
der basal conditions, SNAP-25 immunolabeling was prominent
in cell bodies and processes of neurons (Fig. 3c,d). In contrast,
p-SNAP-25 immunolabeling was relatively low, presumably due
to low basal PKC activity and/or high phosphatase activity. Ap-
plication of TPA did not detectably alter the abundance or cellu-
lar localization of total SNAP-25, but markedly increased
pSNAP-25 immunofluorescence (Fig. 3c,d). Quantification of
fluorescence intensity showed that TPA increased the p-SNAP-
25/total SNAP-25 ratio in dendrites by 50% (control vs TPA;
p-SNAP-25: 100 11% vs 150 9%, p 0.01; total SNAP-25:
100  17% vs 81  15%, p 
 0.4; p-SNAP-25/total SNAP-25:
100  10%, vs 229  40%, n 	 7, p  0.05; Fig. 3d). These
findings indicate that PKC phosphorylates SNAP-25 at Ser-187
in neurons and that after PKC stimulation, p-SNAP-25 is en-
hanced in neuronal processes. The results do not exclude the
possibility that PKC also phosphorylates other targets such as the
Figure 2. PKC phosphorylates SNAP-25 in heterologous cells. a, HEK-293 cells overexpressing WT and S187A SNAP-25 were
treated with TPA (100 nM, 15 min) in the absence or presence of Bis. Cell lysates were subjected to Western blotting and probed
with an antibody that recognizes p-SNAP-25 (top). TPA induced phosphorylation of WT, but not mutant SNAP-25(S187A). Strip-
ping and reprobing with an antibody against total SNAP-25 reveals equal loading of samples and the absence of SNAP-25 in
mock-transfected cells (bottom).b–g, HEK-293 cells overexpressingWTSNAP-25 andSNAP-25(S187A)were fixed, permeabilized
and colabeled with antibodies to p-SNAP-25 and total SNAP-25, followed by Cy3 (red, p-SNAP-25) and AMCA (blue, SNAP-25)-
conjugated secondary antibodies, respectively. b, Under basal conditions, p-SNAP-25 is at background intensity. c, TPA markedly
promotes phosphorylation of SNAP-25, particularly evident at the leading edges of the cell. d, Bis (1M) abolished TPA-induced
phosphorylation of SNAP-25. e, f, TPA does not promote phosphorylation of mutant SNAP-25(S187A). g, Summary bar graph of
results shown in b–f. n	 8–12 for each condition; ***p 0.001.
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presynaptic proteinsmunc-18 (Wierda et al., 2007) and dynamin
(Robinson et al., 1993) and/or that it indirectly phosphorylates
SNAP-25 via activation of another kinase. It should be noted that
at this resolution, it is not possible to distinguish labeling in pre-
versus postsynaptic structures andmay be difficult to distinguish
en passant axons versus dendrites.
PKC-mediated insertion of NMDARs in neurons
is SNARE-dependent
The results reported thus far demonstrate that PKC phosphory-
lates SNAP-25 at Ser187 in neurons, but do not implicate
SNAP-25 as a functionally relevant substrate of PKC phosphor-
ylation in neurons. Toward this end, we undertook three exper-
imental approaches. First, we monitored PKC potentiation of
NMDA-elicited currents by whole-cell patch-clamp recording
from cultured hippocampal neurons (DIV 10–14) pretreated
with inactivated or active botulinum neurotoxin (BoNT) A, an
isoform that cleaves SNAP-25 (but not SNAP-23) and prevents
SNARE-dependent exocytosis (Yao et al., 1999). We reasoned
that if PKC potentiated NMDARs via SNARE-dependent exocy-
tosis, then cleavage of SNAP-25 and/or its binding partners
would prevent PKC potentiation. NMDA currents were elicited
once per minute by bath-application of NMDA (N, 100 M with
10M glycine, 5 s application). Introduction of the constitutively
active form of PKC, PKM (2 nM), via the recording pipette to
neurons rapidly (within 5 min after break-in) potentiated
NMDA currents in cells treated with inactive BoNT A (inacti-
vated by boiling for 5 min; left) by 60% relative to basal cur-
rents (potentiation of the peak to 157  16%, p  0.01;
potentiation of steady state to 140  14%, p  0.02 vs basal
currents; Fig. 4a–c), presumably due in large part to enhanced
delivery of NMDARs to the cell surface (Lan et al., 2001a). Treat-
ment of neurons with BoNT A (200 ng/ml; pretreatment for 1 h)
did not detectably alter basal NMDA currents (data not illus-
trated), but abolished PKC potentiation of NMDA currents of
both peak and steady-state (SS) phases of NMDA currents in
hippocampal neurons (inactive vs active BoNT A: peak, 157 
16% vs 99  2%, n 	 9; p  0.001; steady state, 140  14% vs
106 5%, n	 9; p 0.02; Fig. 4a–c). Consistent with SNARE-
dependent receptor exocytosis, pretreatment with BoNT B (200
ng/ml), which cleaves v-SNARE VAMP2/synaptobrevin-2, also
blocked PKM potentiation of NMDA currents (inactive vs active
BoNT B: peak, 131 5% vs 97 14%, n	 4; p 0.05; supple-
mental Fig. 2, available at www.jneurosci.org as supplemental
material). These findings indicate that PKC potentiation of
NMDA responses in hippocampal neurons occurs via SNAP-25-
mediated, SNARE-dependent exocytosis.
RNAi-mediated depletion of SNAP-25 blocks PKC
potentiation of NMDARs
Second, we examined with the impact of RNAi-mediated knock-
down of SNAP-25 on PKC potentiation of NMDA currents. We
Figure3. PKC phosphorylates SNAP-25 in neurons.a, Dissociated cortical neurons in culture (DIV 9)were treatedwith TPA (100 nM, 15min) in the absence or presence of Bis and the phosphatase
inhibitors okadaic acid (OA, 100 nM) and cyclosporine A (CsA, 2 M), lysed, and protein samples were subjected to Western blots probed with the p-SNAP-25 antibody. TPA induced robust
phosphorylation of SNAP-25 at Ser187 (p-SNAP-25, upper blot, second lane), which was enhanced by phosphatase inhibitors (fourth lane) and blocked by the PKC inhibitor Bis (third lane) even in
thepresenceof phosphatase inhibitors (fifth lane). Strippingand reprobingwithanantibody to total SNAP-25 revealedequal loadingof proteins in all lanes (bottom).b, Summarybargraph showing
p-SNAP-25/SNAP-25normalized to the TPA sample;n	4 independent experiments; *p0.05, ***p0.001. c,d, Hippocampal neurons in the absence (control; 0.01%DMSO) or presence of TPA
treatment were fixed, permeabilized and colabeled with antibodies for p-SNAP-25 and SNAP-25 and decorated with Alexa Fluor 488- and Cy3-conjugated secondary antibodies, respectively.
Representative confocal images showing that neuronal somata and dendrites exhibited low p-SNAP-25 labeling under basal conditions (a); upon TPA stimulation, p-SNAP-25 immunolabeling
markedly increased (b). Bottom, high-magnification images of regions indicated in boxes above.d, Dendritic regionswere selected based on the differential interference contrast (DIC) images, and
values of integrated intensity divided by area were plotted. Summary bar graph showing that intensity levels of p-SNAP-25 (left), but not total SNAP-25 (center), increased. Thus, the ratio of
p-SNAP-25/SNAP-25 increased (right). *p 0.05; **p 0.01.
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designed two RNAi sequences directed
against mouse SNAP-25 cDNA and eval-
uated them separately for their ability to
knockdown SNAP-25 expression inHEK-
293 cells. A generic RNAi that does not
target any known vertebrate gene (non-
targeting (NT)-RNAi), served as a nega-
tive control (pcDNA6.2). Both SNAP-25
RNAi-1 (directed to bps 470–490 of
mouse SNAP-25) and SNAP-25 RNAi-2
(directed to bps 681–701 of SNAP-25),
but not NT RNAi, markedly attenuated
recombinant SNAP-25 protein expres-
sion in HEK-293 cells (48 h after transfec-
tion: RNAi-1: to 17% of control; RNAi-2:
to 30% of control; 72 h after transfection:
both to 4% of control; supplemental Fig.
3, available at www.jneurosci.org as sup-
plemental material). To validate the spec-
ificity and effectiveness of the SNAP-25
RNAi-2 sequence in cells with neuronal
traits, we examined its impact on endoge-
nous SNAP-25 and SNAP-23 abundance
in Neuro2A (N2A) cells. N2A cells were
transfected with a lentiviral transfer vector
driving cocistronic expression of EGFP and
SNAP-25 RNAi-2 (hereafter referred to as
“SNAP-25 RNAi”). Seventy-two hours af-
ter transfection, cells were lysed and sub-
jected to Western blotting for SNAP-25.
SNAP-25 RNAi was highly effective in
that it markedly reduced SNAP-25 pro-
tein abundance relative to that of untrans-
fected cells (not illustrated) or cells
transfectedwithNT(control)RNAi(to18%),
and was specific in that it did not detectably
alter SNAP-23 abundance (Fig. 4d).
To examine the effects of SNAP-25
RNAi onNMDAcurrents in a physiological
milieu, we next infected neurons with lenti-
virus containing SNAP-25 RNAi or NT
RNAi (control) and monitored PKM-
induced potentiation of NMDA currents.
At 48–72 h after transduction, SNAP-25
RNAi was robustly expressed, as evidenced
by intense EGFP fluorescence (data not il-
lustrated). SNAP-25 RNAi induced little ef-
fect onbasalNMDAcurrents, butmarkedly
reduced PKCpotentiation of both peak and
steady-state phases of NMDA-elicited cur-
rents in hippocampal neurons (NT RNAi:
peak, 1498%; steady state, 1256%,n	
4, p  0.01 vs control currents; SNAP-25
RNAi: peak, 102 4%, steady state, 86 7%; n	 4, n.s. vs control
currents; p 0.01 vsNTRNAi; Fig. 4e–g). Thus, SNAP-25 silencing
abolishes PKC potentiation of NMDA responses in hippocampal
neurons. These findings strongly suggest that SNAP-25 is required
for PKC insertion of NMDARs in neurons.
Phosphorylation of SNAP-25 at Ser187 is critical to PKC
insertion of NMDARs in neurons
Third, we expressed WT or mutant SNAP- 25(S187A) via the
pIRES2-EGFP vector in cultured hippocampal neurons and
monitored PKC potentiation of NMDA-elicited currents. The
results thus far implicate a role for SNAP-25 in NMDAR inser-
tion in neurons, but do not address the target of PKC phosphor-
ylation. In neurons expressing WT SNAP-25, PKM potentiated
NMDA currents by80% relative to basal currents within 5–10
min of break-in (potentiation of the peak to 186  33%, p 
0.001; potentiation of steady state to 199 16%, p 0.001; Fig.
5a,b,d). Expression of SNAP-25(S187A) produced no significant
change in basal NMDA-elicited currents neurons relative to WT
SNAP-25 (WT vs S187A, peak, 926 211 vs 635 254 pA, n	
Figure 4. PKC-mediated insertion of NMDARs in neurons requires SNAP-25. a– c, Specific cleavage of SNAP-25 by botulinum
toxinA (BoNTA)blockedPKMpotentiationofNMDAcurrents.a,Whole-cell patch-clamp recordingswereperformedonhippocam-
pal neurons (DIV10–14)pretreatedwith inactivated (Inact.; heatedat95°C for 15min)or activeBoNTA (200ng/ml) for 1hat37°C.
NMDA-elicited currents were monitored every minute by bath-application of NMDA (N, 100M with 10M glycine, 5 s). Consti-
tutively active PKC, PKM (2 nM), introduced via the patch pipette, rapidly (within 5min after break-in) potentiated NMDA currents
in cells treated with inactive BoNT A (left). Treatment of neurons with BoNT A abolished PKM potentiation of NMDA currents
(right). b, c, Summary time course (b) and bar graph (c) showing that active (E), but not inactive (f), BoNT A abolished
PKM potentiation of both peak and steady-state (SS) phases of NMDA currents in hippocampal neurons (n	 9). *p 0.05;
**p 0.01.d–g, RNAi-mediated knockdown of SNAP-25 blocked PKMpotentiation.d, Validation of RNAi-mediated knockdown
of endogenous SNAP-25 in N2A cells. N2A cells were transfected with a lentiviral transfer vector driving expression of EGFP and
SNAP-25 RNAi cocistronically. Seventy-two hours after transfection, cells were lysed and subjected to Western blotting for SNAP-
25. A sequence directed against SNAP-25, but not an unrelated sequence (control), markedly reduced SNAP-25 expression. Strip-
ping and reprobing for -actin revealed equal loading and that SNAP-23 expression is unaffected. *Nonspecific band.
e, Knockdown of SNAP-25 blocks PKM potentiation. Whole-cell recordings were performed on neurons incubated with lentivirus
harboring a specific SNAP-25 RNAi sequence for 48–72 h. SNAP-25, but not control, RNAi afforded complete blockade of PKM
potentiation. f,g, Summary timecourse (f ) andbargraph (g) showing that SNAP-25 (E), butnot control (f), RNAi abolishedPKM
potentiation of both peak and steady-state (SS) phases of NMDA currents (n	 4). **p 0.01.
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5, p
 0.4; steady state, 488 133 vs 452 216 pA, n	 5, p
 0.8;
Fig. 5c), but completely blocked PKM-induced potentiation (WT
vs S187A, peak, 186 33% vs 115 9%, n	 5, p 0.05; steady
state, 199 16% vs 115 20%, n	 5, p 0.01; Fig. 5a,c,d). In
contrast, the phosphomimetic mutant SNAP-25 S187D did not
detectably alter basal NMDAcurrents or PKMpotentiation (sup-
plemental Fig. 4, available at www.jneurosci.org as supplemental
material). Due to the fact that transfection efficiencies in neurons
are low (10%) and that expression ofWTandmutant SNAP-25 is
sparse within a network, these results suggest that manipulations of
postsynaptic SNAP-25 significantly impact on PKC potentiation of
NMDA currents. Together, these findings indicate that PKC phos-
phorylation of serine residue 187 in SNAP-25 is critical to PKC-
induced insertion of postsynaptic NMDARs in neurons.
Because overexpression of exogenous proteins may cause
nonphysiological changes in neurons, we used an additional
complementary strategy to examine a role for Ser187 in SNAP-25
in PKC potentiation of NMDA currents. We applied peptides
corresponding to the C-terminal region of SNAP-25 to acutely
disrupt the interaction of endogenous SNAP-25 with its SNARE
complex binding partners, syntaxin-1 and VAMP2. A SNAP-25
C-terminal peptide mimicking the BoNT A-cleavage fragment
blocks vesicular exocytosis in chromaffin cells (Gutierrez et al.,
1997). As a blocking peptide, we used an 11 aa peptide (corre-
sponding to residues 182–192 of SNAP-25) that contains the
nonphosphorylatable residue Ala in place of Ser at residue 187
flanked on either side by 5 aa (Fig. 6a). As a control, we used an 11
aa peptide with the same residue composition, but in a random-
ized order (scrambled). Dialysis of PKM (2 nM) with the scram-
bled peptide (control, 10 M) via the patch pipette potentiated
NMDA-elicited currents for a period of 5–10 min (peak, 128 
11% of control, n	 7, p 0.05, Fig. 6b,c left; steady state, 115
10% of control, n 	 7, p 
 0.1, Fig. 6b,c right). Application of
chelerythrine (1 M), a selective inhibitor of the PKC catalytic
subunit, reverted the potentiated NMDA responses to their orig-
inal baseline values (Fig. 6b,c). In contrast, application of the
blocking peptide completely abolished PKC potentiation of
NMDA-elicited currents (peak, 96.3 5.0% of control; steady
state, 94.8 2.8% of control; n	 7, p 0.05 blocking vs scram-
bled peptide). PKMpotentiation in the presence of the scrambled
peptide was similar to that achieved in the absence of the peptide
(data not illustrated).
To examine whether PKC-induced phosphorylation of
SNAP-25 selectively regulates insertion of NMDARs or more
generally regulates delivery of ligand-gated ion channels to the
cell surface, we monitored the impact of PKM on -amino-3-
hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR)-
mediated currents in the same cell. After washout of NMDA and
glycine, we recorded currents elicited by 1 s bath application of
S-AMPA (25 M) to hippocampal neurons. Whereas PKM po-
tentiated NMDA-elicited currents in the presence of scrambled
peptide (Fig. 6b,c), it produced no detectable effect on AMPA-
elicited currents (blocking, 100.8 3.3% of control; scrambled,
92.2  3.8% of control; p 
 0.05 for all; Fig. 6d–f right). These
findings strongly suggest that postsynaptic assembly of the
SNARE complex is required for PKC-dependent insertion of
NMDARs (but not AMPARs) in hippocampal neurons.
SNAP-25 mediates PKC potentiation in hippocampal slices
The experiments thus far establish a role for SNAP-25 in PKC-
dependent insertion of NMDARs, but do not distinguish be-
tween synaptic and extrasynaptic NMDARs. To address this
issue, we recorded isolatedNMDAEPSCs (EPSCs) atmossy fiber
(mf)-CA3 synapses of acute hippocampal slices from juvenile rats
in the presence of CNQX and LY303070 (the active isomer of
GYKI-53655) to block kainate receptors and AMPARs, and bicu-
culline to block GABAARs. The PKC-activating phorbol ester
PDBu (1M), delivered via the recording pipette, did not detect-
ably alter the paired-pulse ratio [PPR; control, PPR at 0 min,
2.17 0.32; PPR at 5–10 min, 2.31 0.28; scrambled, PPR at 0
min, 2.50  0.39, Fig. 7a; scrambled, PPR at 5–10 min, 2.76 
0.48 (data not illustrated)], but markedly potentiated NMDA
EPSCs in the absence (data not illustrated) or presence of the
scrambled peptide (control, to 228.8  29.9%, n 	 9, p  0.01;
scrambled, to 235.4 42.6%, n	 7, p 0.01; Fig. 7b,d). As in the
case of NMDA-elicited whole-cell currents recorded from disso-
ciated neurons, application of the SNAP-25 blocking peptide via
the patch pipette did not significantly affect basal NMDA trans-
mission, assessed at 5 min after break-in (blocking peptide,
94.1 15%; n.s. vs basal current in the absence of peptide), but
greatly reduced PDBu potentiation of the NMDA EPSC at mf-
CA3 synapses (scrambled peptide, 235.4 42.6%; blocking pep-
tide, 105.7  8.2%, n 	 7, p  0.05 vs scrambled peptide; Fig.
7b,d). Additionally, dialysis of PKM (1M) into the postsynaptic
Figure 5. Phosphorylation of postsynaptic SNAP-25 at Ser187 is critical to PKC-induced insertion of NMDARs in neurons. a, Representative traces showing PKC potentiation of NMDA responses
in neurons expressing SNAP-25/pIRES2-EGFP. Whole-cell patch-clamp recordings were performed on hippocampal neurons (DIV 7–16) expressing SNAP-25 WT or S187A/pIRES2-EGFP, 1 d after
transfection. PKM in the patch pipette potentiated NMDA currents expressing SNAP-25WT (left). Mutant SNAP-25 (S187A) abolished PKC potentiation of NMDA currents (right). b, Summary time
course of PKM potentiation in cells expressingWT (f) versus mutant SNAP-25(S187A) (E). PKM potentiated the peak (top) and steady-state (SS, bottom) phases of NMDA-elicited currents (n	
5 each). Current amplitudes were normalized to amplitudes of control responses recorded just after break-in (at 0 min). c, d, Expression of SNAP-25(S187A) did not alter the peak or steady-state
phase of basal NMDA currents (c), but abolished PKM-induced potentiation (d). n.s., not significant; *p 0.05; **p 0.02.
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cell potentiatedNMDAEPSCs to 364 76.5%of control by 5–10
min after break-in (Fig. 7c,d). Delivery of an anti-SNAP-25 anti-
body (-SNAP-25) togetherwith PKMgreatly reduced the PKM-
induced potentiation of NMDA EPSCs (from 364 76.5%, n	
8, to 167.4  18.9% n 	 6, p  0.05; Fig. 7c,d). These findings
demonstrate a postsynaptic action of SNAP-25 in PKC-mediated
potentiation of synaptic NMDARs at mf-CA3 synapses.
Activation of PKC promotes NMDAR surface expression
in neurons
The results thus far indicate that PKC potentiates postsynaptic
NMDARs at hippocampal synapses, but do not address the
mechanism by which the potentiation occurs. To address this
issue, we examined the impact of PKC activation on surface ex-
pression ofNMDARs in neurons. Application of TPA in the pres-
ence of the phosphatase inhibitors OA (100 nM) and CsA (2 M)
(but not OA and CsA alone) enhanced the surface expression of
NMDAR subunit NR1 in cortical neurons (DIV 7–10), as as-
sessed by Western analysis of biotinylated cell-surface proteins
(Fig. 8a,b). The increase in NR1 cell surface expression was
blocked by Bis, indicating that it is PKC-mediated, and by BoNT
A, indicating that it is SNARE-dependent [p  0.05 for
TPAOACsA, n	 4 vs control (nontreated), n	 4; Fig. 8b,c].
Total NR1 levels were not detectably altered (Fig. 8b,c). In con-
trast, TPA in the presence of OA and CsA did not significantly
enhance the surface expression of AMPARs as assessed by West-
ern blotting for biotinylated surface GluR1 or GluR2 (GluR1:
OACsA vs OACsATPA, 104  16% vs 100  9%, n 	 3,
Figure 6. Acute disruption of SNAP-25 interactions inhibits PKC-mediated insertion of NMDARs. a, Peptides corresponding to 11 aa in the distal region of the C terminus of SNAP-25 were
synthesized and coappliedwith PKM via the patch pipette into neurons. The blocking peptide (MEKADANKTRI) contained the nonphosphorylatable residue Ala in place of Ser at residue 187 flanked
on either side by 5 aa. The scrambled peptide (KANAKTDEIRM) had the same amino acid composition as the blocking peptide, but in a randomized order. All peptides were used at 10M in the
pipette. b–e, PKM potentiated NMDA but not AMPA currents recorded in the same neuron. b, Representative traces showing that in the presence of the scrambled peptide, PKM potentiated
NMDA-elicited currents in 5–10min. The blocking peptide, containing an Ala in the center, completely abolished PKC insertion of NMDARs. c, Summary time course of those experiments described
inb. Whereas PKMpotentiated NMDAR-mediated currents in the presence of the scrambled (f) peptide, potentiationwas abolished in the presence of the blocking peptide (Œ).d, Representative
traces of AMPA-elicited currents (S-AMPA, 25M) recorded in the same cell as inb, followingwashout of NMDAandglycine, showing that AMPA responseswere not potentiated by PKM in presence
of either peptides. e, Summary time course of those experiments described in d. f, Summary bar graphs illustrating PKC potentiation of NMDA (left), but not AMPA (right), currents in hippocampal
neurons at 9 min. n	 5–7 for each peptide. Error bars represent SEM. *p 0.05; **p 0.01; n.s., nonsignificant.
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p 	 0.84; Fig. 8d,e). These findings are consistent with a model
whereby activation of PKC phosphorylates SNAP-25, which facili-
tates assembly of the SNARE complex and promotes insertion
of new NMDA, but not AMPA, channels at the cell surface
(Fig. 8d).
Discussion
The present study shows that PKC promotes NMDAR insertion
of new NMDA channels in hippocampal neurons in culture and
at mf-CA3 synapses via SNARE-dependent exocytosis. Although
the functional target of PKC potentiation is well established, the
molecular target of PKC is unclear. We further show that SNAP-
25, amember of the SNARE family of vesicular fusion proteins, is
a target of PKC phosphorylation functionally relevant to
NMDAR trafficking. Several independent findings indicate
that PKC-induced phosphorylation of SNAP-25 at Ser187
(and assembly of the SNARE complex) are critical to regulated
delivery of NMDARs at the cell surface. First, dominant negative
SNAP-25 reduced both basal and, in corroboration of Lan et al.
(2001a), potentiated NMDA-elicited currents in oocytes. Second,
RNAi-mediated depletion of SNAP-25 and BoNT A-mediated
cleavage of SNAP-25 abolished PKM potentiation of NMDA cur-
rents in neurons. Third, overexpression of SNAP-25(Ser187Ala)
abolished PKC potentiation of NMDA-elicited currents in oocytes
and neurons. Fourth, acute disruption of SNAP-25 function by
introduction of a blocking peptide corresponding to the C
terminus of SNAP-25 phosphorylated at Ser187 attenuated
PKC-induced insertion of NMDARs in
hippocampal neurons and slices. Fifth,
introduction of a function-blocking
SNAP-25 antibody into the postsynaptic
cell markedly inhibited PKC potentiation
of the NMDA EPSCs at CA3 synapses in
acute hippocampal slices. Our findings
that PKC promotes insertion of new
NMDA channels at the postsynaptic side
of mf-CA3 synapses in a SNARE-
dependent manner are consistent with
findings of others (Kwon and Castillo,
2008). These findings, together with our
finding that SNAP-25 is a target of PKC
phosphorylation functionally relevant to
NMDAR trafficking, provide a molecular
mechanism bywhich activity induces LTP
of NMDA-EPSCs at this synapse (Kwon
and Castillo, 2008; Rebola et al., 2008).
Whereas SNAP-25 is critical to regulated,
PKC-dependent exocytosis of NMDARs,
SNAP-23 mediates constitutive exocytosis
of NMDAR transport packets in cortical
neurons prior to synapse formation (Wash-
burn et al., 2004) and constitutive cycling of
NMDARs at CA1 synapses of cultured hip-
pocampal slices (Suh et al., 2009).
SNAP-25 and syntaxin-1 (target or
t-SNAREs) localize to the plasma mem-
brane, where they dock with vesicular
“v-SNAREs” such as VAMP2 andmediate
fusion of cargo-loaded vesicles with
the plasma membrane (Su¨dhof and
Rothman, 2009). PKCphosphorylation of
SNAP-25 at Ser187 promotes assembly of
the SNARE complex and thereby facili-
tates recruitment of vesicles at the presyn-
aptic membrane (Nagy et al., 2002). Based on findings in the
present study, we propose a model whereby PKC phosphoryla-
tion of SNAP-25 at Ser187 also promotes insertion of NMDARs
at the postsynapticmembrane (Fig. 8f). PKC also phosphorylates
munc-18 (Wierda et al., 2007) and dynamin (Robinson et al.,
1993), which regulate vesicular release at the presynaptic mem-
brane. The finding of stable endocytic zones in regions lateral to
the synapse/PSDofmature neurons (Blanpied et al., 2002; Ra´cz et
al., 2004) indicates that receptors diffuse laterally from the syn-
apse (where they are tightly anchored) to the perisynaptic re-
gion (where they are more mobile) to undergo endocytosis.
Although not yet identified, exocytic zones may also localize
lateral to PSDs. PKC phosphorylation of SNAP-25 could pro-
mote rapid insertion of new NMDA channels by recruiting
NMDAR-loaded vesicles from recycling endosomes to the
postsynaptic membrane by analogy to activity-dependent inser-
tion of AMPARs (Park et al., 2004).
SNARE-dependent glutamate receptor trafficking
The specificity of PKC for SNAP-25 phosphorylation and
NMDAR insertion is indicated by several findings. First, phos-
phorylation of Ser187, but not Ser28 and Thr29, is critical to
PKC-dependent insertion of NMDARs in oocytes and neurons).
Second, RNAi against SNAP-25 (but without effect on SNAP-23)
abolishes PKC potentiation of NMDARs in neurons. Third,
whereas PKCpotentiatesNR2A- andNR2B-containing NMDARs, it
Figure 7. SNAP-25 is required for PKC-induced synaptic insertion of NMDARs in hippocampal slices. a–d, Synaptic NMDA
currents (NMDA EPSCs) were recorded from CA3 pyramidal neurons in the presence of CNQX, LY303070, and picrotoxin (to block
kainate receptors, AMPARs and GABAA receptors), and 1mMMg
2 (to reduce Mg2 block) at Vh	40mV. Mossy fibers were
activated by paired-pulse electrical stimulation in the dentate gyrus. a, b, Representative traces (a) and time course data (b)
showing that application of thePKC-activatingphorbol ester PDBu (1M, delivered via the recordingpipette solution) potentiated
NMDA EPSCs in the presence of the scrambled peptide (as in Fig. 6). Loading the postsynaptic cell with the SNAP-25 blocking
peptide abolished PKC potentiation. b, Representative time course data showing block of PKC potentiation by blocking peptide
(E), but not by scrambled peptide (●). c, An anti-SNAP-25-antibody greatly reduced PKC-induced potentiation of NMDA EPSC.
Summary time course showing that the catalytic subunit of PKC, PKM (1M, delivered via the patch pipette), potentiated NMDA
EPSC; a function-blocking anti-SNAP-25 antibody (-SNAP-25) inhibited PKM potentiation. Each data point was the average of
6–8 experiments in which responses were binned every minute. d, Summary of data in a– c. All data are expressed as means
SEMs of percent control response at break in. *p 0.05; **p 0.01.
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does not potentiate NR2C- or NR2D-
containing receptors in Xenopus oocytes
(Mori et al., 1993). Fourth, PKC potenti-
ation is greater for NMDARs containing
the short NR1 splice variants, NR1-3 and
NR1-4, versus NMDARs containing long
NR1 isoforms (Durand et al., 1992, 1993).
Fifth, whereas PKM promotes postsynap-
tic SNAP-25-dependent insertion of
NMDARs (present study) and SNAP-25-
dependent internalization of kainate re-
ceptors (Selak et al., 2009), it does not
alter AMPAR trafficking (present study).
These findings are consistent with find-
ings that high-frequency stimulation
(HFS) potentiates NMDA-, but not
AMPA-, synaptic currents in a PKC-
dependent manner at mf-CA3 synapses
(Kwon and Castillo, 2008). Whereas con-
ventional PKM potentiates NMDA but
not AMPA currents, atypical PKMzeta
promotes surface expression of AMPARs
but not NMDARs (Ling et al., 2006). The
catalytic site of PKMzeta differs structurally
from that of conventional and novel PKCs
and would thus be expected to affect dis-
tinct molecular targets (Sacktor, personal
communication). Our findings are also
consistent with findings that NMDARs
and AMPARs are transported to synaptic
sites via distinct vesicles (Fong et al., 2002;
Washbourne et al., 2002b) and are sorted
via different intracellular pathways (Jeyi-
fous et al., 2009) in hippocampal neurons.
Whereas AMPARs undergo forward traf-
ficking to the plasma membrane via the
conventional somatic Golgi network,
NMDARs traffic via a nonconventional
secretory pathway involving CASK, SAP97
and dendritic Golgi outposts (Jeyifous et al., 2009) in close prox-
imity to NMDARs and far from intracellular AMPARs.
It is well established that PKC acts via Src to regulate NMDAR
function (Lu et al., 1999), and that genetic deletion of Src blocks
PKM potentiation (Lu et al., 1999). PKC phosphorylates and
activates Src (Lu et al., 1999), which in turn phosphorylates Tyr
residues on theC-terminal tails ofNR2 subunits, thereby increas-
ing channel open probability and mean open time (Yu et al.,
1997). Although Fyn kinase-dependent phosphorylation of
NR2B at Tyr1472 promotes constitutive delivery of synaptic
NMDARs (Prybylowski et al., 2005), Src itself does not regulate
NMDAR trafficking. A possible scenario is that whereas PKC acts
via SNAP-25 to regulates NMDA trafficking (Lan et al., 2001a), it
acts via Src to regulate intrinsic NMDA channel function. In that
event, loss of either SNAP-25 or Src would be sufficient to atten-
uate PKC potentiation of NMDA currents.
We found that the phosphomimetic mutant SNAP-
25(S187D) did not detectably alter basal NMDA currents or
PKC-mediated trafficking of NMDARs in neurons. Although
phosphomimetic mutants may mimic the actions of phosphory-
lated proteins, in many cases they do not (Richard L. Huganir,
Leonard K. Kaczmarek, personal communications). Given that
an aspartate (or glutamate) residue approximates the negative
charge, but is not structurally identical to, a phosphorylated
serine, this is not surprising. Thus, our negative findings in the
case of SNAP-25(S187D) argue neither for nor against a role of
SNAP-25 S187 phosphorylation in PKC potentiation of NMDA
currents in neurons. Our finding that neither the (S187A) and
(S187D)mutants affects basal NMDAcurrents in neurons is con-
sistent with findings that the SNAP-25 blocking peptide does not
alter basal synaptic NMDA currents at CA3 synapses (present
study; Kwon and Castillo, 2008) and that overexpression of the
SNAP25(S187A) mutant does not detectably alter basal NMDA
currents. Our finding in neurons is in contrast to our finding that
the S187D mutant potentiates NMDA currents and partially oc-
cludes PKC potentiation in oocytes. There are several possible
explanations for the differences in oocytes versus neurons. First,
whereas the oocytes express a pure population of NR1/NR2A
receptors, neurons express heterogeneous NMDARs. Second, syn-
aptic receptors localize to postsynaptic densities together with
scaffolding, adaptor and signaling proteins which modify their
trafficking and function and are not necessarily expressed in oo-
cytes. Third, whereas we bath-applied phorbol esters to oocytes,
we delivered recombinant PKM via the patch pipette to neurons.
Fourth, neurons may employ different mechanisms for con-
stitutive versus regulated trafficking of NMDAs. The experi-
ments in neurons are more physiologically relevant and more
likely to reflect PKC-dependent regulation of NMDARs and
Figure 8. PKC activation enhances surface expression of NMDARs via SNAP-25. a, Timeline of experiment. After 45 min incu-
bation with BoNT A (200 ng/ml), cortical neurons (DIV 7–10) were treated with phosphatase inhibitors OA (100 nM) and CsA (2
M), followed by TPA to activate PKC. Fifteen minutes after TPA incubation, cell surface proteins were biotinylated with EZ-Link
Sulfo NHS-SS, cells lysed and surface proteins pulled down with NeutrAvidin beads and subjected to Western blotting for NR1.
b, TPA-induced insertion of NMDARs at the cell surface is PKC-mediated and SNARE-dependent. Representative Western blot
showing that TPAOACsA enhanced surface expression of NMDARs relative to control (untreated) or OA and CsA alone; the
increase in surface expression was blocked by Bis and BoNT A. Treatments did not alter total NR1 levels. c, Summary bar graph
showing that BoNT A significantly inhibited the increase in NMDAR surface expression induced by TPAOACsA (n	 4). *p
0.05. d, e, Representative Western blots probed for GluR1 and GluR2 (d) and summary bar graph (e) showing that TPA, in the
presence of OA and CsA, does not enhance surface expression of AMPARs. f, Proposed model showing that activation of PKC
phosphorylates SNAP-25 and promotes insertion of new NMDA, but not AMPA, channels at the cell surface, consistent with
trafficking of AMPARs and NMDARs in distinct postsynaptic vesicles and delivery to the plasmamembrane via distinct pathways of
exocytosis.
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synaptic plasticity involving NMDAR insertion at hippocampal
synapses.
Regulated NMDAR trafficking in synaptic plasticity
Recent studies indicate that synaptic NMDAR number and/or
subunit composition are also regulated in response to neuronal
activity and sensory experience (Wenthold et al., 2003; Pe´rez-
Otan˜o and Ehlers, 2005; Lau and Zukin, 2007), and that
NMDARs serve not only as the trigger of synaptic plasticity, but
mayalso contribute to the expressionofLTPandLTD(Grosshans et
al., 2002; Watt et al., 2004). In adult rats, HFS promotes PKC-
dependent, SNARE-dependent insertion of NMDARs atmf-CA3
synapses (LTPNMDAR) (Kwon and Castillo, 2008). Given that
LTP-inducing protocols can induce SNAP-25 phosphoryla-
tion (Genoud et al., 1999), HFS may act via phosphorylation
of SNAP-25 to promote insertion of NMDARs and elicit
LTPNMDAR. In addition to activation of NMDARs, stimulation of
group I mGluR (mGluR1 and 5) can induce LTP of NMDA EP-
SCs (O’Connor et al., 1994; Jia et al., 1998; Kwon and Castillo,
2008). Moreover, activation of group I mGluRs promotes deliv-
ery of NMDA channels to the cell surface (Lan et al., 2001b).
These observations raise the possibility that mGluRs could in-
duce PKC-dependent phosphorylation of SNAP-25 and promote
NMDAR insertion at the plasma membrane. Regulation of
NMDAR trafficking provides a powerful mechanism for altering
transmission efficacy and neuronal excitability during synaptic
plasticity and remodeling.
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Supplementary Fig. 1. TPA-induced phosphorylation of SNAP-25 is mediated by PKC. Cortical neurons 
in culture were treated with TPA (100 nM, 15 min) in the absence or presence of various kinase inhibitors. 
Cell lysates were subjected to Western blotting and probed with p-SNAP-25 (upper panel). TPA induced 
phosphorylation of SNAP-25, which was completely abolished when pre-treated with (15 min) the specific 
PKC inhibitor bisindoylmaleimide I Bis (1 µM) and markedly inhibited by another PKC inhibitor 
Chelerythrine (Chel, 10 µM). PKA inhibitors (PKI14-22, PKI, 1 µM and H89, 10 µM) and a CaMKII inhibitor 
(KN93, 10 µM) did not markedly affect SNAP-25 phosphorylation. Stripping and reprobing with an 
antibody against total SNAP-25 reveals equal loading of samples (lower).  
 
Supplementary Fig. 2. VAMP2/synaptobrevin-2 is required for PKM potentiation. (a) Hippocampal 
neurons were pretreated with BoNT B (200 ng/ml, 1 h), which specifically cleaves VAMP2, and NMDA 
currents were monitored in the presence of PKM in the patch pipette. Active (○), but not inactive (■), 
BoNT B abolished PKM potentiation of both peak and steady-state (SS) phases of NMDA currents in 
hippocampal neurons (b,c) Summary time-course (b) and bar graph (c) of data shown in a. n = 4; *, P < 
0.05; n.s., non-significant.  
 
Supplementary Fig. 3. RNAi-mediated knockdown of recombinant SNAP-25. Two DNA sequences 
directed against independent regions of SNAP-25 were subcloned into the pcDNA6.2-GW/EmGFP vector 
(pcDNA6.2). HEK-293 cells were mock-transfected (no SNAP-25 or pcDNA6.2), co-transfected with 
pcDNA6.2 and SNAP-25 or pcDNA6.2 harboring 2 different RNAis that target different sequences of the 
SNAP-25 cDNA. Both SNAP-25 RNAi sequences induced robust knockdown of SNAP-25 expression at 
48 and 72 h, as assessed by Western blotting. Stripping and reprobing with an antibody against β-actin 
reveals equal loading of samples in all lanes and the presence of GFP in cells expressing pcDNA6.2 
constructs.  
 
Supplementary Fig. 4. Normal PKM-induced potentiation of NMDA currents in neurons expressing 
SNAP-25 S187D. We recorded NMDA-evoked current in hippocampal neurons (DIV12-14) expressing 
SNAP-25 S187D/pIRES2-EGFP in the presence of PKM in the patch pipette. Expression of mutant 
SNAP-25 S187D allowed PKM-induced potentiation of NMDA currents.  




